19 December 2019 in Irish Journal of Medical Science (1971 -)
26 May 2018 in Balkan Medical Journal
Background: Carotid artery stenosis (CAS) is the atherosclerotic narrowing of the proximal internal carotid artery (ICA) and one of the main causes of stroke. Elevated expression of the pleiotropic proinflammatory cytokine, interleukin-18 (IL18), has been shown in human atherosclerotic plaques. Aims: To investigate whether IL18 and interleukin-18 binding protein (IL18BP) mRNA expression and IL18 -137 G/C (rs187238) variants are associated with CAS development. Study Design: Case-control study.Methods: IL18 and IL18BP mRNA expression and IL18 rs187238 variants were evaluated by quantitative real-time polymerase chain reaction (RT-qPCR) and real-time PCR, respectively, in peripheral blood mononuclear cells (PBMCs) of 70 patients with CAS (36 symptomatic, 34 asymptomatic) and 75 healthy controls. Results: IL18 mRNA expression was significantly increased in CAS patients compared to healthy controls (p=0.01). However, there was no significant difference between IL18BP mRNA levels in patients with CAS and controls (p=0.101). ICA stenosis severity was higher in symptomatic patients than in asymptomatic patients (p<0.001). A borderline significant relationship was identified between IL18 expression and ICA stenosis severity in patients with CAS (p=0.051). IL18 rs187238 polymorphism genotype frequencies did not significantly differ between patients with CAS and controls (p=0.246). A significant difference was identified between IL18BP gene expression and symptomatic and asymptomatic patients (p=0.026) but no difference in IL18 expression was observed between the symptomatic and asymptomatic subgroups (p=0.397). Conclusion: This study suggests that IL18 mRNA expression may affect CAS etiopathogenesis and ICA stenosis severity. Furthermore, our results indicate that IL18BP may play a mechanistic role in the pathogenesis of CAS, influencing symptom appearance.
29 May 2017 in Sao Paulo Medical Journal
KEY WORDS: Neoplasm metastasis; Adenocarcinoma; Echocardiography; Heart failure; Pulmonary artery
23 May 2022 in Turkish Journal of Biochemistry
Objectives: Coronary artery disease (CAD) is a pathological condition resulting from atherosclerosis in the coronary arteries. IL17A has been shown to recruit and activate macrophages in atherosclerotic lesions, thereby participating in plaque destabilization. Currently, whether OLR1 and IL17A variants are involved in the pathogenesis of CAD is unclear. This case-control study aimed to investigate their roles in CAD etiology and prognosis. Methods: In this study, 100 severe CAD patients who had undergone the coronary artery bypass graft surgery and 100 healthy controls were genotyped for OLR1 rs11053646, IL17A rs3819025, and rs8193037 variants via RT-PCR. Results: The patients with OLR1 rs11053646 CG + GG genotype demonstrated a higher frequency of multi-vessel stenosis (18%) than single- (11.10%) or double-vessel (13.30%) stenosis (p=0.77). Additionally, although not statistically significant, this group of patients had 6.280 times more CAD risk than CC genotype carriers (p=0.089). Furthermore, logistic regression analysis revealed significant associations between the three variants and the risk factors for CAD development, namely waist circumference (p=0.002), body mass index (p=0.013), fasting glucose level (p=0.006), and triglyceride levels (p=0.035). Conclusions: OLR1 rs11053646, IL17A rs3819025, and rs8193037 variants do not increase the risk for CAD development. However, this conclusion should be confirmed with a larger cohort.
8 December 2023 in Namık Kemal Tıp Dergisi